Skip to main content

Table 5 Multivariate 5-year survival and event rates estimated by the corrected group analysis method

From: The adherence paradox: guideline deviations contribute to the increased 5-year survival of breast cancer patients

Cohort

  

Survival

Event

Hazard

95 % confidence interval

Test

Samples

Comparison groups

rate

rate

ratio

Lower bound

Upper bound

p-value

1996–97

Institutional-invasive

Guideline divergence

76.8

23.2

1.612

0.690

3.766

n.s.

  

Guideline adherence

84.5

15.5

1996–97

Regional-invasive

Guideline divergence

79.9

20.1

1.293

0.500

3.348

n.s.

  

Guideline adherence

83.4

16.2

2003–04

Institutional-invasive

Guideline divergence

86.3

13.7

1.147

0.581

2.266

n.s.

  

Guideline adherence

87.7

12.2

2003–04

Regional-invasive

Guideline divergence

84.0

16.0

1.914

0.772

4.745

n.s.

  

Guideline adherence

91.0

9.0

Guideline-adherence

Institutional-invasive

1996–97

89.6

10.4

1.036

0.333

3.229

n.s.

  

2003–04

89.9

10.1

Guideline-adherence

Regional-invasive

1996–97

87.1

12.9

1.922

0.453

8.161

n.s.

  

2003–04

92.2

7.8

Guideline-divergence

Institutional-invasive

1996–97

76.4

23.7

1.665

1.113

2.490

0.013

  

2003–04

84.6

15.4

Guideline-divergence

Regional-invasive

1996–97

79.6

20.4

1.196

0.734

1.947

n.s.

  

2003–04

82.5

17.5

  1. Legend: First row of each comparison yields higher hazard and lower/equal survival (effect coding)